Published : 25 Jun 2019

---

A Belgium based synthetic biology specialist company developing original genetic technologies using bacteriocins has appointed Aagami to support out-licensing of their 2 key patented technologies which increase yield and remove contamination.

 

The client has demonstrated its technology’s efficacy at lab / pilot scale and is working with customers to use this technology for the production of recombinant products (application in sterile condition).

 

Most recently, a LARGE Skin & Hair care Global Giant plans using our client’s technology , and is poised to launch a product using it by 2021.

Aagami team are keen to get multiple licensing deals done for their new client.